【24h】

Selective boosting of tumor subvolumes.

机译:肿瘤亚体积的选择性增强。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE AND BACKGROUND: It is no longer considered mandatory to deliver a uniform dose to the tumor volume in radiotherapy. Non-uniform doses are unavoidable in brachytherapy and in stereotactic radiosurgery, with often good results. Deliberately non-uniform doses may increase tumor control probability (TCP) and enable steeper dose gradients outside the treated volume to be achieved. New methods of tumor imaging might show regions of specific activity or hypoxia which could be selectively targeted. This paper investigates by modeling the effect of boosting, by dose ratios up to 2, for a range of tumor subvolumes. METHODS AND MATERIALS: A standard linear-quadratic algorithm was used to define the dose-response curve for tumors of various volumes (numbers of clonogenic cells), radiosensitivity (SF(2)), assumed slope (gamma(50)) and dose for 50% tumor control (TCD(50)). Curves of tumor control probability (TCP) were constructed to show the increase of TCP, as a function of the ratio of boost dose to the TCD(50), above the baseline 50% TCP, for a set of different proportions of tumor volume boosted. RESULTS: Calculated values of TCP increased rapidly with both boost dose ratio and with proportion of volume boosted. The increase in TCP reached a plateau after boost dose ratios of 1.2-1.3, as has been noted before, except where very large proportions of tumor volume exceeding 90% were boosted. Quite large increases of TCP, to about 75%, could be achieved if the gamma(50) slope was steep, and especially in small tumors (having fewer cells). Radiosensitivity was not an independent factor because radiosensitive tumors had a low TCD(50) and this was the baseline dose considered as unity. CONCLUSION: There were few situations where a boost dose ratio exceeding 1.3 appeared to be worthwhile or necessary. Significant increases of TCP, up from 50% to 75%, might therefore be achieved for a small increase in risk of necrosis, where a substantial proportion of tumor volume (60-80%) could be boosted.
机译:目的和背景:在放射治疗中,不再需要向肿瘤体积内均匀剂量地给药。在近距离放射治疗和立体定向放射外科中不可避免地会出现剂量不一致的情况,通常效果良好。故意不均匀的剂量可能会增加肿瘤控制概率(TCP),并使治疗体积以外的剂量梯度更为陡峭。肿瘤成像的新方法可能会显示具有特定活性或缺氧的区域,可以将其选择性靶向。本文通过对高达2的剂量比对一系列肿瘤亚体积的增强作用进行建模研究。方法和材料:使用标准的线性二次算法来定义各种体积(克隆细胞数量),放射敏感性(SF(2)),假定斜率(γ(50))和剂量的肿瘤的剂量反应曲线50%肿瘤控制(TCD(50))。构建了肿瘤控制概率(TCP)曲线,以显示对于一组不同比例的肿瘤体积,TCP的增加作为基线剂量50%TCP之上的加强剂量与TCD(50)的比率的函数。结果:TCP的计算值随剂量比和体积比的增加而迅速增加。如前所述,在增加剂量比例为1.2-1.3之后,TCP的增加达到了平稳状态,除非其中很大一部分肿瘤体积超过90%被增强。如果gamma(50)斜率陡峭,特别是在小肿瘤(细胞较少)中,TCP可以大大提高,达到大约75%。放射敏感性不是一个独立因素,因为放射敏感性肿瘤的TCD(50)低,这是被视为统一剂量的基线剂量。结论:在少数情况下,增加剂量比超过1.3似乎是值得或必要的。因此,由于坏死风险的小幅增加,可以实现TCP的显着增加(从50%增至75%),其中大量肿瘤体积(60-80%)可以得到增强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号